Microcrystalline Cellulose Market Size, Share, Regional Growth, 2026-2034
- jhon smith
- 3 days ago
- 4 min read
Market Overview
According to fortune business insights, the global microcrystalline cellulose market size was valued at USD 3.96 billion in 2025. The market is projected to grow from USD 4.21 billion in 2026 to USD 6.85 billion by 2034, exhibiting a CAGR of 6.30% during the forecast period. Asia Pacific dominated the microcrystalline cellulose market with a market share of 39.00% in 2025.
These insights are part of a comprehensive research report, titled “Microcrystalline Cellulose Market, 2026-2034.”
The analysis shows that companies are investing more in microcrystalline cellulose (MCC) as it becomes an indispensable excipient. Its increasing use as a premier binding and disintegrating agent in the pharmaceutical industry, along with its growing role as a clean-label texturizer in food products, indicates strong and expanding demand worldwide.
Major Players Profiled in the Market Report:
• ASAHI KASEI CORPORATION (Japan)
• NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD. (India)
• Sigachi Industries. (India)
• Ankit Pulps and Boards Pvt. Ltd. (India)
• DFE Pharma (Germany)
• SEPPIC (France)
• Apollo Scientific (U.K.)
• International Flavors & Fragrances Inc. (U.S.)
• JRS PHARMA (Germany)
• Roquette Frères (France)
Segments
Consistent Quality and Reliable Production to Propel Wooden Based Segment Growth
Based on source, the market is bifurcated into wooden based and non-wooden based. The wooden based segment holds the largest market share and dominates the market owing to its well-established supply chains, consistent quality, and reliable production processes, which are critical for regulated industries like pharmaceuticals.
Critical Role as an Excipient to Drive Pharmaceutical Segment Expansion
By application, the market is segmented into pharmaceutical, food & beverages, personal care & cosmetics, paints & coatings, and others. The pharmaceutical segment is leading the market as MCC serves as a critical excipient, providing essential functionality as a binder, disintegrant, and flow enhancer in tablet formulations.
High Versatility and Preference in Formulations to Drive Powdered Form Segment Growth
Based on form, the market is categorized into powdered and liquid. The powdered segment holds the largest market share owing to its high preference and versatility across diverse applications, particularly in solid dosage pharmaceutical formulations where it is a primary excipient.
Report Coverage
The report offers:
• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
• Comprehensive insights into regional developments.
• List of major industry players.
• Key strategies adopted by the market players.
• The latest industry developments include product launches, partnerships, mergers, and acquisitions.
Drivers & Restraints
Growing Adoption as a Premier Pharmaceutical Excipient to Propel Market Growth
The rapid growth in the global pharmaceutical industry, driven by rising tablet production and innovations in drug delivery, has raised the demand for high-quality excipients. MCC is favored for its exceptional compressibility, chemical inertness, and stability, boosting the microcrystalline cellulose market growth.
However, the volatility in the supply and price of high-quality wood pulp, coupled with capital-intensive manufacturing requirements, creates cost pressures and may hamper market growth.
Regional Insights
Expanding Pharmaceutical Manufacturing Propels Market Growth in Asia Pacific
Asia Pacific holds the dominant microcrystalline cellulose market share and is projected to experience strong growth during the forecast period. The region’s growth is attributed to the expansion of pharmaceutical manufacturing and processed food industries in China and India, driven by a rising middle class and increasing consumption.
Strong Demand from Regulated Industries in the U.S. Propels Market Growth in North America
North America is a significant and mature market. The region’s growth is attributed to its sophisticated pharmaceutical and food processing sectors, where stringent FDA regulations and demand for clean-label products favor the use of high-quality, reliable ingredients like MCC.
Microcrystalline Cellulose Market Future Growth:
The microcrystalline cellulose market is experiencing robust growth, fueled by rising demand from the pharmaceutical and food & beverage industries. Today’s consumers and manufacturers are increasingly drawn to clean-label and natural ingredients, positioning MCC as a preferred alternative to synthetic additives. Additionally, there is a growing interest in sustainable sourcing from agricultural waste and developing specialized MCC grades for high-growth areas like plant-based foods and controlled-release drugs. The rapid expansion of pharmaceutical production in emerging markets is also a key growth driver. While Asia Pacific dominates due to its expanding manufacturing base, North America and Europe continue to lead in demand for premium, high-functionality grades.
Competitive Landscape
Growing Adoption of Sustainable Practices to Propel Market Growth
The market features prominent players like DFE Pharma, Roquette Frères, and ASAHI KASEI CORPORATION. These leading companies are accelerating growth through strategic initiatives such as innovating product functionality, adopting sustainable manufacturing practices, expanding production capacities, and ensuring strict regulatory compliance to meet rising global demand.
Key Industry Development
• March 2025: IFF Pharma Solutions showcased next-gen excipients at CPHI Japan 2025, including low-nitrite microcrystalline cellulose (Avicel PH LN).
• February 2024: Asahi Kasei introduced Ceolus, a pharmaceutical-grade MCC, and commenced operations at a second production facility in Japan to enhance supply capacity and stability.
• October 2023: Roquette Pharma Solutions unveiled three new excipient grades, including MICROCEL 103 SD and 113 SD (microcrystalline cellulose variants), designed to stabilize moisture-sensitive formulations.
Comments